NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13D Oct 12, 2018
4 Oct 11, 2018 PRIMARY DOCUMENT
NT 10-K Sep 28, 2018 NT 10-K
8-K/A Sep 12, 2018 FORM 8-K/A
8-K Jul 23, 2018 FORM 8-K
8-K Jul 19, 2018 FORM 8-K
8-K Jul 11, 2018 FORM 8-K
10-Q May 21, 2018 10-Q
NT 10-Q May 15, 2018 NT 10-Q
4 May 4, 2018 FORM 4
8-K May 4, 2018 FORM 8-K
10-Q Feb 20, 2018 10-Q
NT 10-Q Feb 14, 2018 FORM 12B-25
8-K Dec 15, 2017 FORM 8-K
424B5 Nov 22, 2017 424B5
10-Q Nov 14, 2017 10-Q
DEFR14A Nov 8, 2017 DEFR14A
DEF 14A Oct 27, 2017 DEF 14A
10-K Sep 28, 2017 10-K
10-Q May 15, 2017 10-Q
EFFECT Apr 25, 2017
CORRESP Apr 20, 2017
CORRESP Apr 18, 2017
S-3/A Apr 18, 2017 S-3/A
UPLOAD Mar 15, 2017
← Newer Page 8 of 23 · 556 filings Older →